The Goal of Every H1N1 Swine Flu Vaccine: Immunotoxicity, Neurotoxicity and Sterility

The Goal of Every H1N1 Swine Flu Vaccine:
Immunotoxicity, Neurotoxicity and Sterility

Science dictates that only a randomized double-blind, placebo-controlled study can generate unbiased results in any clinical trial. In the history of vaccine development, no such study has ever been performed. It is only unscientific opinions and pharmaceutical propaganda which have propelled the mythological validity, safety and effectiveness of vaccines. Dozens of controlled studies have scientifically verified the immunotoxicty, neurotoxicity and sterility of common vaccine ingredients which destroy human health, yet they are all ignored by conventional medicine.

There should be a public outcry and challenge to every public health official, medical specialist or scientist (from any country) who justifies the inoculation of their population without providing the evidence of safety and effectiveness of the respective H1N1 vaccine in their country.

The public should be demanding that their governments materialize at least one vaccine trial which is randomized, double-blind and placebo-controlled that can scientifically validate the assertions of public health officials.

Since the pharmacokinetic properties of vaccines are not studied, vaccine manufacturers cannot deny any of the toxic effects listed below. The reason they never analyze the absorption, distribution, metabolism or excretion of these ingredients is because it would eradicate the vaccine industry. However the individual effects of each ingredient and their toxic effects on cells are well documented.

Every Physician, Nurse or medical personnel who administers the H1N1 vaccine (or any vaccine) should be asking themselves why they are injecting the following ingredients into patients that have been scientifically proven to cause immunotoxicity, neurotoxicity, sterility and cancer:

Novartis Focetria Adjuvanted H1N1
Influenza Vaccine Ingredients/Toxicity
Polysorbate 80: Sterilie Agent
Potassium Chloride: Neurotoxin
Squalene: Neurotoxin
Thimerosal: Neurotoxin

Novartis H1N1 Monovalent Influenza Vaccine Ingredients/Toxicity
Beta-Propiolactone: Carcinogen
Polymyxin: Neurotoxin
Neomycin: Immunotoxin
Thimerosal: Neurotoxin

GlaxoSmithKline Arepanrix Adjuvanted
H1N1 Influenza Vaccine Ingredients/Toxicity
Formaldehyde : Carcinogen
Polysorbate 80: Sterilie Agent
Sodium Deoxycholate: Immunotoxin
Squalene: Neurotoxin
Thimerosal: Neurotoxin

GlaxoSmithKline Pandemrix Adjuvanted
H1N1 Influenza Vaccine Ingredients/Toxicity
Octoxynol 10: Immunotoxin
Polysorbate 80: Sterilie Agent
Potassium Chloride: Neurotoxin
Sodium Deoxycholate: Immunotoxin
Squalene: Neurotoxin
Thimerosal: Neurotoxin

GlaxoSmithKline Fluarix 2009-2010
Formula Ingredients/Toxicity
Formaldehyde : Carcinogen
Octoxynol 10: Immunotoxin
Polysorbate 80: Sterilie Agent
Sodium Deoxycholate: Immunotoxin

Sanofi-Pasteur H1N1 Influenza Vaccine Ingredients/Toxicity
Formaldehyde : Carcinogen
Polyethylene Glycol : Systemic Toxin
Thimerosal: Neurotoxin

MedImmune H1N1 Vaccine Ingredients/Toxicity
Monosodium Glutamate: Neurotoxin
Gentamicin Sulfate: Nephrotoxic
Monobasic Potassium Phosphate: Immunotoxin

FLUARIX 2009 Latest Package Insert Ingredients/Toxicity
Formaldehyde : Carcinogen
Gentamicin Sulfate: Nephrotoxic
Polysorbate 80: Sterilie Agent
Sodium Deoxycholate: Immunotoxin
Thimerosal: Neurotoxin

CSL PANVAX H1N1 Vaccine Ingredients/Toxicity
Beta-Propiolactone: Carcinogen
Neomycin: Immunotoxin
Sodium Taurodeoxycholate: Carcinogen/Immunotoxin
Polymyxin: Neurotoxin
Thimerosal: Neurotoxin

CSL Afluria H1N1 Influenza Vaccine Ingredients/Toxicity
Beta-Propiolactone: Carcinogen
Neomycin Sulfate: Immunotoxin
Polymyxin B: Neurotoxin
Potassium Chloride: Neurotoxin
Sodium Taurodeoxycholate: Carcinogen/Immunotoxin
Thimerosal: Neurotoxin

Note: An additional CSL H1N1 Vaccine is Undergoing Trials with AS03 Adjuvant which contains Squalene.

Adverse Reactions of Vaccines

Pain
Redness
Swelling
Fatigue
Headaches
Arthralgia (joint inflammation)
Myalgia (muscle inflammation)
Shivering
Sweating
Swollen lymph nodes
Fever
Vomiting
Tingling or numbness of the hands or feet
Shortness of breath
Vasculitis (inflammation of the blood vessels)

Serious adverse reactions are as follows:

Blood and lymphatic system disorders (lymphadenopathy)

Psychiatric disorders (insomnia)

Nervous system disorders (dizziness, paraesthesia, inflammation of the central nervous system, inflammation of nerves, autoimmune disorders affecting myelin sheaths of nerves such as Guillain-Barré Syndrome)

Ear and labyrinth disorders (vertigo)

Respiratory, thoracic and mediastinal disorders (dyspnoea)

Gastrointestinal disorders (nausea, diarrhea, abdominal pain, vomiting, dyspepsia, stomach discomfort)

Skin and subcutaneous tissue disorders (pruritus, rash)

Musculoskeletal and connective tissue disorders (back pain, musculoskeletal stiffness, neck pain, muscle spasms, pain in extremity)

General disorders and administration site conditions (bruising, asthenia, chest pain, malaise)

* Download this PDF

* A full list of h1n1 vaccine ingredients, alerts and warnings.

Reference Sources: 226, www.novaccine.com
October 30, 2009